Skip to main content
Premium Trial:

Request an Annual Quote

Fisher Scientific to Acquire Perbio in Move Toward Proteomics

NEW YORK, June 26 - Fisher Scientific has moved to acquire Swedish reagent supplier Perbio in a move toward proteomics, the companies said today.

 

Fisher, headquartered in Hampton, N.H., will make a $714 million cash offer for all outstanding Perbio shares and warrants on the Stockholm Stock Exchange, and said it has unanimous support from Perbio's board of directors.

 

Perbio supplies consumables for protein research and drug production.

 

"Fisher is one of the most respected names in the life science community, and our focus on proteins has positioned Perbio right at the heart of the biotech revolution," said Mats Fischier, Chairman of Perbio, in a statement.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.